- Research article
- Open Access
The impact of central line insertion bundle on central line-associated bloodstream infection
BMC Infectious Diseases volume 14, Article number: 356 (2014)
Knowledge about the impact of each central line insertion bundle on central line-associated bloodstream infection (CLABSI) is limited.
A quality-improvement intervention, including education, central venous catheter (CVC) insertion bundle, process and outcome surveillance, have been introduced since March 2013. Outcome surveillances, including CLABSI per 1,000 catheter-days, CLABSI per 1,000 inpatient-days, and catheter utilization rates (days of catheter use divided by total inpatient-days), were measured. As a baseline measurement for a comparison, we retrospectively collected data from March 1, 2012 to December 31, 2012.
During this 10-month period, there were a total of 687 CVC insertions, and 627 (91.2%) insertions were performed by intensivists. The rate of CLABSI significantly declined from 1.65 per 1000 catheter-day during the pre-intervention period to 0.65 per 1000 catheter-day post-intervention period (P = 0.039). CLABSI more likely developed in subjects in which a maximal sterile barrier was not used compared with subjects in which it was used (P = 0.03). Moreover, CVC inserted by non-intensivists were more likely to become infected than CVC inserted by intensivists (P = 0.010).
This multidisciplinary infection control intervention, including a central line insertion care bundle, can effectively reduce the rate of CLABSI. The impact of different care bundle varies, and a maximal sterile barrier precaution during catheter insertion is an essential component of the care line insertion bundle.
In conjunction with the increasing use of central venous catheters (CVC) among critically ill patients, the occurrence of central line-associated bloodstream infections (CLABSI) is increasing. Recent studies have shown that this serious complication could result in increasing mortality, morbidity and hospital stay length [1–6]. Therefore, several evidence-based interventions, including the use of chlorhexidine gluconate (CHG) skin preparations and maximal sterile barriers during insertion, use of the subclavian or internal jugular vein instead of the femoral vein, hand hygiene, and daily review of line necessity, were developed to prevent CLABSI [7–10]. Moreover, these strategies were compiled into a “central line bundle” by the Institute for Healthcare Improvement (IHI).
To reduce the CLABSI rate in intensive care units (ICU), we introduced a multidimensional program, which included the implementation of central line bundle, education and surveillance investigations, in five adult ICUs in a regional hospital in southern Taiwan. The aim of this study was to evaluate the different impacts of each bundle on the ICU CLABSI rate from March 2013 to December 2013. To clarify the overall effect of this multidisciplinary team care bundle, we used the rate of CLABSI in the same period (from March to December) in 2012 as reference for the purpose of comparison.
This study was conducted in five adult ICUs at a regional teaching hospital, which had 63 ICU beds (including 26 beds for surgical ICU, 23 for medical ICU, and 14 for cardiac care unit) and eight intensivists. Beginning in March 2013, a quality-improvement intervention, including education, CVC insertion bundle, and process and outcome surveillance, were introduced in the ICU. In March, all ICU members, including physicians and nurses, were educated about the scope and practice of each central line bundle. The education program included the three times of lectures for all ICU personnel and the creation of teaching video which provided instruction for site selection, skin preparation, draping, insertion and dressing the central venous catheter. All of ICU members were asked to watch the video. The insertion bundle included four components: hand hygiene, maximal sterile barriers upon insertion, use of CHG for skin preparations, and avoidance of the femoral vein as the access site . The maintenance bundle included hand hygiene, proper dressing changes, aseptic technique for accessing and changing needleless connectors, and a daily review of catheter necessity. Process surveillance through the use of a checklist was developed to assess the compliance of four bundle practices and compliance was defined as the frequency of the number of each bundle performed to the number of CVC insertions. Between March 1 and December 31, 2013, the compliance to the CVC insertion bundle was observed. Outcome surveillance, including CLABSI per 1,000 catheter-days, CLABSI per 1,000 inpatient-days, and catheter utilization rates (days of catheter use divided by total inpatient-days), were measured. The data were collected on a routine basis and the analysis was carried out retrospectively. Therefore, informed consent was not required and was specifically waived by the Institution Review Board. Ethics approval was obtained from Institution Review Board of Chi Mei Medical Center.
The CLABSI was defined as a primary laboratory confirmed bacteremia or fungemia (excluding skin flora – Corynebacterium spp, Baccilus spp. Propionibacterium spp., coagulase-negative Staphylococci, Streptococcus viridans, Aerococcus spp, Micrococcus spp) in a patient with a central line at the time of (or within 48-hours prior to) the onset of symptoms and the infection is not related to an infection from another site . The diagnosis was made jointly by a team of that included the infection control practitioner and intensivists. As a baseline measurement for a comparison, we retrospectively collected the same data from March 1, 2012 to December 31, 2012.
All significant variables in the univariate analyses were included in a logistic-regression model to identify the most important factors associated with the rate of CLABSI. A P value < 0.05 was considered statistically significant. The chi-square analysis of the trend was used to assess temporal changes in the rate of infection and catheter utilization. All statistical analyses were conducted using the statistical package SPSS for Windows (Version 19.0, SPSS, Chicago, Il, USA).
During this 10-month period in the ICU, there were a total of 18,656 inpatient-days and 9,388 catheter-days. The overall catheter utilization rate was 50.3%. Among a total of 687 CVC insertions on 481 patients (134 patients had multiple catheter insertions), 627 (91.2%) insertions were performed by intensivists. Additionally, 38 (5.5%), 12 (1.7%), and 10 (1.5%) CVC insertions were performed by cardiologists, trained residents, and surgeons, respectively. The internal jugular vein was the most common site of CVC insertion (n = 375, 54.6%), followed by the femoral vein (n = 261, 40.0%) and the subclavian vein (n = 51, 7.4%). The overall compliance of all four components of central line insertion bundles was 55.2%. The compliance of each component was as follows: 100% for hand hygiene, 99.6% for the use of CHG, 87.3% for maximal sterile barrier precaution, and 62.2% for optimal site selection.
During this intervention period, there were six CLABSI occurring in six patients, and these infections were diagnosed 7 – 15 days after insertion. The overall rate of CLABSI was 0.64 per 1,000 catheter-days and 0.32 per 1,000 inpatient-days. Candida species compromised 4 CLABSI cases, and each one was caused by methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus. Five CLABSIs were CVC-related and one was double-lumen catheter-related. Three catheters were inserted via the femoral vein, and three central line insertions did not follow the precaution of maximal sterile barrier during insertion. In addition, three infected central lines were inserted by intensivists, followed by a cardiologist (n = 2) and a surgeon (n = 1). The overall compliance of all four insertion bundles of these CLABSI cases was only 33.3%.
Furthermore, we compared the adherence to each CVC insertion bundle between patients with CLABSI and patients without CLABSI (Table 1). We found that CLABSI was more likely to develop in subjects in which a maximal sterile barrier was not used than in subjects in which it had (P = 0.03). Moreover, CVCs inserted by non-intensivists were more likely to become infected than CVCs inserted by intensivists (P = 0.010). Additionally, CLABSI were more likely in CCU than in MICU and SICU. However, the occurrence of CLABSI was not found to be associated with the type of catheter, site of insertion, hand hygiene, use of 2% CHG, or even the completeness of four insertion bundles. The results of the multivariate analysis disclosed that maximal sterile barrier upon insertion and CVC insertions by intensivists were independently associated with the lower rate of CLABSI. The associated odds ratios (OR) and 95% confidence intervals (CI) are displayed in Table 2.
To further evaluate the effect of the implementation of central line bundle, we compared the rate of CLABSI and catheter utilization between the same 10-months period in 2012 and 2013 (Figure 1). Between March and December in 2012, there was a total of 20,059 inpatient-days and 10,325 catheter-days. The overall catheter utilization rate was 51.4%, and a total of 17 episodes of CLABSI developed during this period (Table 3). We found the rate of CLABSI significantly declined, from 1.65 per 1000 catheter-day during pre-intervention period to 0.64 per 1000 catheter-day post-intervention period (P = 0.039). In other words, the rate of CLABSI decreased from 0.84 per 1000 inpatient-days during the pre-intervention period to 0.32 per 1000 catheter-day during the post-intervention period (P = 0.034). In contrast, the catheter utilization rate remained stable (P = 0.11).
Our investigation in adult ICUs in a regional hospital had several significant findings. First, our findings indicated that the rate of CLABSI can be significantly reduced after implementation of a multidisciplinary quality-improvement intervention, including a central line insertion care bundle. This result is consistent with previous studies [13–19] of different settings (ICU and wards), populations (adult and children), and countries (developed and developing countries). Despite the fact that the bundle care in each study may not be identical, all of these studies suggest that CLABSI can be effectively controlled by applying a multidisciplinary infection control process.
Although we attempted to implement bundle care, including hand hygiene, maximal sterile barriers upon insertion, use of CHG for skin preparation, and avoidance of the femoral vein for the access site in this quality-improvement process, the overall compliance of all four bundles was only 50.3%. The compliance in our study is much lower than a previous study by Osorio et al., in which the staff adherence to the insertion bundle was over 80% in ICUs in Colombia . Moreover, the compliance of the optimal insertion site selection and maximal sterile barrier was only 87% and 62%, respectively. In contrast, the compliance was more than 99% for hand hygiene and use of 2% CHG. It indicated that the process surveillance instigation is warranted to find out the specific deficit of the quality-improvement process. Based on our findings, we should try harder to enhance the adherence to these two CVC insertion bundles, maximal sterile barrier and optimal site selection, in our institution.
To facilitate the maximal sterile barrier, we required that critical care nurses assist with this procedure. Therefore, nurses as well as physicians need to wear masks, sterile gowns, caps, and sterile gloves during CVC insertion, which is labor-intensive and time-consuming. Thus, maximal sterile barrier sometimes cannot be fully applied, especially in the emergency conditions. Finally, the compliance of maximal sterile barrier was low in the present study.
Despite four major components are at the same time included in the central line insertion bundle in the present work, we found the associations between each component and the occurrence of CLABSI were different. Only maximal sterile barrier during insertion was found to be significantly associated with a lower CLABSI rate (OR: 0.141, 95% CI: 0.028-0.709). Our findings and a previous study  indicate that this precaution, maximal sterile barrier upon insertion, is essential for the prevention of CLABSI. In contrast, the optimal site of insertion (femoral vein or non-femoral vein access) was not found to be significantly associated with the occurrence of CLABSI. A recent systematic review and meta-analysis  by Marik et al. concluded there was no difference in the CLABSI rate with femoral venous catheters compared to subclavian and internal jugular venous catheters in recent studies. In addition, a multicenter randomized trial showed the femoral and internal jugular access had a similar risk of CLABSI while subclavian access in not possible . Therefore, although the avoidance of femoral vein access is recommended as part of central line insertion bundle, the benefit of this measure on the occurrence of CLABSI remains unclear. In summary, our results suggest that maximal sterile barrier during insertion may be the most effective preventive strategy among the four central line insertion bundles.
In addition to bundle care, a CVC inserted by the intensivist was found to be a protective factor for CLABSI in the present work (OR: 0.091, 95% CI: 0.018-0.463). This significance could be explained by the fact that intensivists may have more experience and be more familiar with the insertion of CVC than non-intensivists (77.0% vs 38.1%, p < 0.001). Additionally, our previous study11 demonstrated that the performance of CVC insertion bundles was significant better for intensivists than non-intensivist staff (63.9% vs 28.6%, p < 0.001), indicating that CVCs inserted by intensivists in an ICU had the higher compliance of bundle care and lower risk of CLABSI than CVCs inserted by non-intensivists.
Finally, a recent meta-analysis on quality improvement interventions for CLABSI prevention suggested an additional preventive effect through use of bundles/checklists . It reminds that the use of a bundle/checklist with compliance measurement should be another important intervention, and it can identify gaps in prevention measure compliance specific to individual ICUs. Thus, the hospital administrators can develop training programs for those interventions with lower rates of compliance to further enhance the quality-improvement.
This study has several limitations. First, we conducted this investigation at a single institution; therefore, our findings may not be generalizable to other hospitals. The difference between external and internal validity should therefore be more nuanced. In other ICUs the compliance with these care items will differ, so the impact of maximal sterile barrier precautions on the CLABSI rate will be different when there are different maximal sterile barrier compliance rates between hospitals/ICUs. An ICU with 80% maximal sterile barrier use will not benefit as much from a quality improvement bundle encouraging compliance with maximal sterile barrier precautions versus an ICU with 20% compliance. Second, the study was conducted during a short period of time (ten months). Third, we only investigated the impact of the central line insertion bundle on CLABSI but did not evaluate the effect of the central line maintenance bundle. However, the maintenance care of the central line did not have a significant change during the study period. Thus, the impact of maintenance bundle in this study may be minimal. Finally, although a longer catheter duration is a well-known risk factor for CLABSI insertion, these data were not available.
In summary, this multidisciplinary infection control intervention, including a central line insertion care bundle, can effectively reduce the rate of CLABSI. The impact of different care bundle varies, and a maximal sterile barrier upon insertion is an essential component of the care line insertion bundle.
Centers for Disease Control and Prevention (CDC): Vital signs: central line-associated bloodstream infection – United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011, 60: 243-248.
Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS: Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units. Infect Control Hosp Epidemiol. 2013, 36: 893-899.
Boyce JM: Prevention of central line-associated bloodstream infections in hemodialysis patients. Infect Control Hosp Epidemiol. 2012, 33: 936-944.
Rosenthal VD: Central line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis. 2009, 49: 1899-1907.
Rosenthal VD, Guzman S, Migone O, Crnich CJ: The attributable cost length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care department in Argentina: a prospective, matched analysis. Am J Infect Control. 2003, 34: 475-480.
Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castañon J, Franco G, Tabal-Galan N, Ruiz J, Duarte P, Graves N: Attributable cost and length of stay for patients with central venous catheter venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol. 2007, 28: 31-35.
Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006, 355: 2725-2732.
Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, Sona CS, Buchman TG, Boyle WA, Polish LB, Fraser VJ: Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med. 2002, 30: 59-64.
Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, Rigaud JP, Casciani D, Misset B, Bosquet C, Outin H, Brun-Buisson C, Nitenberg G, French Catheter Study Group in Intensive Care: Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001, 286: 700-707.
Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP: Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994, 15: 231-238.
Leung PO, Lin HL, Lin YH, Lai CC: Different compliance of central line insertion bundle between intensivists and non-intensivist staffs in intensive care unit. Infect Control Hosp Epidemiol. 2014, 35: 601-603.
Edwards JR, Peterson KD, Andrus ML, Tolson JS, Goulding JS, Dudeck MA, Mincey RB, Pollock DA, Horan TC, Facilities N: National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control. 2007, 35: 290-301.
Rosenthal VD, Maki DG, Rodrigues C, Alvarez-Moreno C, Leblebicioglu H, Sobreyra-Oropeza M, Berba R, Madani N, Medeiros EA, Cuéllar LE, Mitrev Z, Dueñas L, Guanche-Garcell H, Mapp T, Kanj SS, Fernández-Hidalgo R, International Nosocomial Infection Control Consortium Investigators: Impact of international nosocomial infection control consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countires. Infect Control Hosp Epidemiol. 2010, 31: 1264-1272.
Rosenthal VD, Ramachandran B, Villamil-Gómez W, Armas-Ruiz A, Navoa-Ng JA, Matta-Cortés L, Pawar M, Nevzat-Yalcin A, Rodríguez-Ferrer M, Yıldızdaş RD, Menco A, Campuzano R, Villanueva VD, Rendon-Campo LF, Gupta A, Turhan O, Barahona-Guzmán N, Horoz OO, Arrieta P, Brito JM, Tolentino MC, Astudillo Y, Saini N, Gunay N, Sarmiento-Villa G, Gumus E, Lagares-Guzmán A, Dursun O: Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the international nosocomial infection control consortium (INICC). Infect. 2012, 40: 415-423.
García-Rodríguez JF, Alvarez-Díaz H, Vilariño-Maneiro L, Lorenzo-García MV, Cantón-Blanco A, Ordoñez-Barrosa P, Mariño-Callejo AI, Sesma-Sánchez P: Epidemiology and impact of a multifaceted approach in controlling central venous catheter associated blood stream infections outside the intensive care unit. BMC Infect Dis. 2013, 13: 445-
Rinke ML, Chen AR, Bundy DG, Colantuoni E, Fratino L, Drucis KM, Panton SY, Kokoszka M, Budd AP, Milstone AM, Miller MR: Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics. 2012, 130: e996-e1004.
Dogru A, Sargin F, Celik M, Sagiroglu AE, Goksel MM, Sayhan H: The rate of device-associated nosocomial infections in a medical surgical intensive care unit of a training and research hospital in Turkey: one-year outcomes. Jpn J Infect Dis. 2010, 63: 95-98.
Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ: Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control. 2003, 31: 405-409.
Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N: The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med. 2005, 33: 2022-2027.
Osorio J, Álvarez D, Pacheco R, Gómez CA, Lozano A: Implementation of an insertion bundle for prevention central line-associated bloodstream infections in an intensive care unit in Colombia. Rev Chilena Infectol. 2013, 30: 465-473.
Marik PE, Flemmer M, Harrison W: The risk of catheter-related bloodstream infection with femoral venous catheter as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012, 40: 2479-2485.
Timsit JF, Bouadma L, Mimoz O, Parienti JJ, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Herrault MC, Schwebel C, Ruckly S, Souweine B, Lucet JC: Jugular versus femoral short-term catheterization and risk of infection in intensive care units patients. Causal analysis of two randomized trials. Am J Respir Crit Care Med. 2013, 188: 1232-1239.
Blot K, Bergs J, Vogelaers D, Blot S, Vandijck D: Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis. 2014, Apr 9. [Epub ahead of print]
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/356/prepub
All of the authors reported no conflict of interest relevant to this article.
HJ and HL draft the manuscript, YH, PO, and YC participated in the design of the study, CC drafted and completed the manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Tang, HJ., Lin, HL., Lin, YH. et al. The impact of central line insertion bundle on central line-associated bloodstream infection. BMC Infect Dis 14, 356 (2014). https://doi.org/10.1186/1471-2334-14-356
- Central line bundle
- Central line-associated bloodstream infection